{
  "trial_id": "NCT04591626",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 2 diabetes, HbA1c, body mass index (BMI), weight, insulin glargine dose, metformin dose, acarbose dose, fasting blood glucose (FBG), estimated glomerular filtration rate (eGFR), serum calcitonin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of type 2 diabetes",
        "body mass index (BMI)",
        "weight",
        "insulin glargine dose",
        "metformin dose",
        "acarbose dose",
        "fasting blood glucose (FBG)",
        "estimated glomerular filtration rate (eGFR)",
        "serum calcitonin"
      ]
    },
    "processed-gen-response": "Age, gender, duration of type 2 diabetes, HbA1c, body mass index (BMI), weight, insulin glargine dose, metformin dose, acarbose dose, fasting blood glucose (FBG), estimated glomerular filtration rate (eGFR), serum calcitonin."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Daily Insulin Dose, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Blood Glucose, Renal Function (eGFR), Weight,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Duration of Diabetes",
        "Daily Insulin Dose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Blood Glucose",
        "Renal Function (eGFR)",
        "Weight"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Daily Insulin Dose, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Blood Glucose, Renal Function (eGFR), Weight"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Body Mass Index, Duration of Diabetes, HbA1c, Insulin Glargine Dose, Metformin Dose, Acarbose Dose, Fasting Blood Glucose, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetes",
        "Insulin Glargine Dose",
        "Metformin Dose",
        "Acarbose Dose",
        "Fasting Blood Glucose",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Region of Enrollment, Body Mass Index, Duration of Diabetes, HbA1c, Insulin Glargine Dose, Metformin Dose, Acarbose Dose, Fasting Blood Glucose, Systolic Blood Pressure, Diastolic Blood Pressure."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting blood glucose (FBG), insulin glargine dose, metformin and/or acarbose dose, weight, systolic blood pressure, diastolic blood pressure, heart rate, medical history (including cardiovascular disease, ketoacidosis, hypoglycemia, gastric emptying abnormality, pancreatitis, renal disease), smoking status, ethnicity.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Hemoglobin A1c (HbA1c)",
          "HbA1c at screening"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting blood glucose (FBG)",
        "insulin glargine dose",
        "metformin and/or acarbose dose",
        "weight",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "medical history (including cardiovascular disease, ketoacidosis, hypoglycemia, gastric emptying abnormality, pancreatitis, renal disease)",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting blood glucose (FBG), insulin glargine dose, metformin and/or acarbose dose, weight, systolic blood pressure, diastolic blood pressure, heart rate, medical history (including cardiovascular disease, ketoacidosis, hypoglycemia, gastric emptying abnormality, pancreatitis, renal disease), smoking status, ethnicity."
  }
}